Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus [...] (Q27675449)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus [...] |
scientific article |
Statements
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease (English)
Craig W Lindsley
Susan C Baker
Anna M Mielech
Valerie Grum-Tokars
Yahira M Baez-Santos
Jon Jacobs
Ya Zhou
Mark Turlington
S Adrian Saldanha
Peter Chase
Aimee Eggler
Eric S Dawson
Peter Hodder
Shaun R Stauffer
3 January 2013
2 references
Identifiers
2 references
2 references
2 references